Drug could be promising new option against eczema
A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition—eczema.
by ·
A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition—eczema.
by · Published June 4, 2021
by · Published April 23, 2021
by · Published June 9, 2021